83 related articles for article (PubMed ID: 23292242)
1. Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT.
Rovó A; Aljurf M; Chiodi S; Spinelli S; Salooja N; Sucak G; Hunter A; Kim TS; Socié G; van Lint MT; Passweg JR; Arat M; Badoglio M; Tichelli A
Bone Marrow Transplant; 2013 Jun; 48(6):878-9. PubMed ID: 23292242
[No Abstract] [Full Text] [Related]
2. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study of a telehealth delivered, psychoeducational support group for allogeneic hematopoietic stem cell transplant patients.
Lounsberry JJ; Macrae H; Angen M; Hoeber M; Carlson LE
Psychooncology; 2010 Jul; 19(7):777-81. PubMed ID: 19653332
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT.
Piccin A; McCann S; Socié G; Oneto R; Bacigalupo A; Locasciulli A; Marsh J; Schrezenmeier H; Tichelli A; Hand E; Lawler M; Passweg J;
Bone Marrow Transplant; 2010 Jun; 45(6):1008-13. PubMed ID: 19915627
[TBL] [Abstract][Full Text] [Related]
5. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
6. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
[TBL] [Abstract][Full Text] [Related]
7. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G
Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
[TBL] [Abstract][Full Text] [Related]
8. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children.
Kondo M; Kojima S; Horibe K; Kato K; Matsuyama T
Bone Marrow Transplant; 2001 Apr; 27(7):727-30. PubMed ID: 11360113
[TBL] [Abstract][Full Text] [Related]
10. Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study.
Hwang JP; Roundtree AK; Giralt SA; Suarez-Almazor M
BMJ Support Palliat Care; 2012 Dec; 2(4):344-50. PubMed ID: 24654219
[TBL] [Abstract][Full Text] [Related]
11. Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation.
Peters C; Ladenstein R; Minkov M; Pötschger U; Gadner H; Cornish J; Dini G; Klingebiel T; Locatelli F; Vossen J; Niethammer D
Bone Marrow Transplant; 1998 Sep; 22(5):431-7. PubMed ID: 9733265
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.
Maury S; Lemoine FM; Hicheri Y; Rosenzwajg M; Badoual C; Cheraï M; Beaumont JL; Azar N; Dhedin N; Sirvent A; Buzyn A; Rubio MT; Vigouroux S; Montagne O; Bories D; Roudot-Thoraval F; Vernant JP; Cordonnier C; Klatzmann D; Cohen JL
Sci Transl Med; 2010 Jul; 2(41):41ra52. PubMed ID: 20650872
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
14. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
[TBL] [Abstract][Full Text] [Related]
16. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb HJ
Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
[TBL] [Abstract][Full Text] [Related]
17. Proposal for standard recommendations for prophylaxis of graft-versus-host disease in children. European Group for Blood and Marrow Transplantation (EBMT) Working Party Paediatric Diseases and the International Study Committee of the BFM family-subcommittee Bone Marrow Transplantation (IBFM-STG).
Peters C; Minkov M; Gadner H; Klingebiel T; Niethammer D
Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S57-60. PubMed ID: 9630328
[TBL] [Abstract][Full Text] [Related]
18. Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bogunia-Kubik K; Mlynarczewska A; Wysoczanska B; Lange A
Haematologica; 2005 Mar; 90(3):425-6. PubMed ID: 15749687
[TBL] [Abstract][Full Text] [Related]
19. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors.
Hows JM; Passweg JR; Tichelli A; Locasciulli A; Szydlo R; Bacigalupo A; Jacobson N; Ljungman P; Cornish J; Nunn A; Bradley B; Socié G; ;
Bone Marrow Transplant; 2006 Dec; 38(12):799-805. PubMed ID: 17075568
[TBL] [Abstract][Full Text] [Related]
20. Severe phimosis as a notable sequela of allogeneic stem cell transplantation in boys.
Suzuki D; Kobayashi R; Kaneda M; Sato T; Ichikawa M; Ariga T
Bone Marrow Transplant; 2007 Aug; 40(4):335-8. PubMed ID: 17572709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
